|

C-CAR031 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Zhejiang University1
  • Shanghai AbelZeta Ltd.1

Indications

  • Cancer2
  • Liver Disease1
  • Squamous Cell Lung Cancer1
  • Liver Cancer1
  • Hepatocellular Carcinoma1

Other2 trials

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
Phase 1
An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.